Thyroid transcription factor-1 amplification and expressions in lung adenocarcinoma tissues and pleural effusions predict patient survival and prognosis

Journal of Thoracic Oncology

Volumn 7, Issue 1, 2012, Pages 76-84

  Li, Xiao ^a   Wan, Liyan ^a   Shen, Hong ^a   Geng, Jian ^a   Nie, Jing ^a   Wang, Guobao ^a   Jia, Nan ^a   Dai, Meng ^a   Bai, Xiaoyan ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

FISH; Lung adenocarcinoma; MPE; Survival; TTF1

Indexed keywords

MESSENGER RNA; THYROID TRANSCRIPTION FACTOR 1;

ARTICLE; CANCER PATIENT; CANCER SURVIVAL; CANCER TISSUE; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MALIGNANT PLEURAL EFFUSION; MICROARRAY ANALYSIS; OVERALL SURVIVAL; PLEURA EFFUSION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 84655166521     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e318232b98a     Document Type: Article

References (15)

1. Guazzi S, Price M, De Felice M, et al. Thyroid nuclear factor 1 (TTF-1) contains a homeodomain and displays a novel DNA binding specificity. EMBO J 1990;9:3631-3639.
2. Barletta JA, Perner S, Iafrate AJ, et al. Clinical significance of TTF-1 protein expression and TTF-1 gene amplification in lung adenocarcinoma. J Cell Mol Med 2009;13:1977-1986.
3. Kwei KA, Kim YH, Girard L, et al. Genomic profiling identifies TITF1 as a lineage-specific oncogene amplified in lung cancer. Oncogene 2008;27:3635-3640. (Pubitemid 351793793)
4. Travis WD, Brambilla E, Noguchi M, et al. The new IASLC/ATS/ERS international multidisciplinary lung adenocarcinoma classification. J Thoracic Oncol 2011;6:244-285.
5. Travis WD, Garg K, Franklin WA, et al. Bronchioloalveolar carcinoma and lung adenocarcinoma: the clinical importance and research relevance of the 2004 World Health Organization pathologic criteria. J Thorac Oncol 2006;1(Suppl 9):S13-S19. (Pubitemid 47181353)
6. Motoi N, Szoke J, Riely GJ, et al. Lung adenocarcinoma: modification of the 2004 WHO mixed subtype to include the major histologic subtype suggests correlations between papillary and micropapillary adenocarcinoma subtypes, EGFR mutations and gene expression analysis. Am J Surg Pathol 2008;32:810-827.
7. Jiang HY, Zhang SQ, Zhao T. A new method to make nuclei or cell microarrays. Diagn Mol Pathol 2006;15:109-114. (Pubitemid 44350488)
8. Summersgill BM, Shipley JM. Fluorescence in situ hybridization analysis of formalin fixed paraffin embedded tissues, including tissue microarrays. Methods Mol Biol 2010;659:51-70.
9. Bai XY, Shen H. Mutational analysis of thyroid transcription factor-1 gene (TTF-1) in lung carcinomas. In Vitro Cell Dev Biol Anim 2008; 44:17-25.
10. Kendall J, Liu Q, Bakleh A, et al. Oncogenic cooperation and coamplification of developmental transcription factor genes in lung cancer. Proc Natl Acad Sci USA 2007;104:16663-16668. (Pubitemid 350211073)
11. Weir BA, Woo MS, Getz G, et al. Characterizing the cancer genome in lung adenocarcinoma. Nature 2007;450:893-898. (Pubitemid 350231325)
12. Perner S, Wagner PL, Soltermann A, et al. TTF1 expression in nonsmall cell lung carcinoma: association with TTF1 gene amplification and improved survival. J Pathol 2009;217:65-72.
13. Tanaka H, Yanagisawa K, Shinjo K, et al. Lineage-specific dependency of lung adenocarcinomas on the lung development regulator TTF-1. Cancer Res 2007;67:6007-6011. (Pubitemid 47037477)
14. Tang X, Kadara H, Behrens C, et al. Abnormalities of the TITF-1 lineage-specific oncogene in NSCLC: implications in lung cancer pathogenesis and prognosis. Clin Cancer Res 2011;17:2434-2443.
15. Wistuba II, Gazdar AF. Lung cancer preneoplasia. Annu Rev Pathol 2006;1:331-348